Tom Swallow

Biography

 Tom Swallow is the Vice President of Finance and Administration at Nohla. Mr. Swallow has over 30 years of finance and accounting experience at both public and private companies. In his previous role, Mr. Swallow served as Vice President, Finance at VentiRx since 2011. Before joining VentiRx, Mr. Swallow served as Senior Director, Finance for Calistoga Pharmaceuticals, a privately held biotechnology company developing innovative therapeutics for patients with cancer or inflammatory diseases (Calistoga was acquired by Gilead in April 2011). At Calistoga, Mr. Swallow was responsible for managing finance and accounting operations and financial system implementation. Prior to Calistoga, Mr. Swallow worked at ICOS, a public biotechnology company engaged in the discovery and development of product candidates for the treatment of serious medical diseases, where he held the position of Controller and then Director of Finance. Mr. Swallow worked at ICOS from its inception through its acquisition by Eli Lily in January 2007. During his tenure at ICOS, Mr. Swallow was responsible for SEC reporting, investment management, and financial planning and analysis. Mr. Swallow also worked as Senior Director, Finance for Targeted Genetics and as an Accounting Manager for Maryatt Industries. Mr. Swallow holds a B.S. in Accounting from Central Washington University.

Research Interest

 Oncology